Dear Dr. Roach: Would it be possible for you to explain my recent diagnosis of monoclonal gammopathy of uncertain significance (MGUS)? Apparently, 3% to 5% of the population over the age of 50 show ...

Monoclonal gammopathy is characterized by an abnormal monoclonal (M)-protein in the blood. This protein is associated with renal toxicity related to the underlying gammopathy. "The key finding of our ...

All patients with multiple myeloma have had MGUS, so what is it? To learn about how multiple myeloma can develop, it’s important to first learn about a plasma cell disorder called monoclonal ...

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma are both precursor conditions that can turn into multiple myeloma, a type of cancer that affects plasma cell production ...

Reviewed by Catherine Lai, MD, MPH, Director of Leukemia, Assistant Professor, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center Patients who receive a diagnosis of a ...

A new research perspective was published in Oncotarget's Volume 15 on January 16, 2024, entitled, “Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma.” Multiple ...

Every year, scientists learn more about multiple myeloma, a type of blood cancer that starts in your bones. They’re working to figure out what causes this cancer and why some groups have a higher ...

GLP-1RA use was associate with lower risks for cardiovascular events among patients with monoclonal gammopathy of undetermined significance and type 2 diabetes. Use of glucagon-like peptide-1 receptor ...

Share on Pinterest Researchers continue to study the risk factors for the blood cancer multiple myeloma. Abraham Gonzalez Fernandez/Getty Images Smoking, poor sleep, and obesity may increase the risk ...